Dual Vaccine Trial in Myeloproliferative Neoplasms

NCT04051307 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Polycythemia Vera
Essential Thrombocythemia

Interventions

DRUG: PD-L1 peptide: PD-L1 Long(19-27) Peptide sequence: FMTYWHLLNAFTVTVPKDL
DRUG: Arginase1 peptide: ArgLong2(169-206) Peptide sequence ISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRL

Sponsor

Inge Marie Svane